November 7-8, 2014
Pediatric Soft Tissue Sarcoma Symposium + International Think Tank 2014
Los Angeles, California: On Friday, November 7, a group of international experts on pediatric soft tissue sarcomas will participate in an invitation-only workshop on paratesticular rhabdomyosarcoma, followed by a Think Tank on pediatric soft tissue sarcomas. On Saturday, November 8, doors open to parents, caregivers, survivors, and medical professionals of all fields. Our full day of expert presentations, Q&A panels, and networking opportunities will inspire learning at all levels. Learn more.
November 13-15, 2014
5th SPAEN Annual Conference in Amsterdam
Amsterdam, Netherlands: This conference aims to provide Sarcoma, GIST and Desmoid patient advocates with an opportunity to share experience and best practice, as well as to learn about advances and challenges in the treatment of rare cancers. The three day conference will focus on research, treatment and access to treatment and advocacy/capacity building. Leading European Sarcoma Experts and others will join us to present the latest medical news and answer your questions.
November 17-20, 2014
Madrid Boston Orthopaedic Pathology Course
Madrid, Spain: The English course (with Spanish translation) offers orthopaedic surgeons, pathologists and radiologists greater knowledge of the scientific foundations of musculoskeletal pathology, in which the roles of the orthopaedic surgeon, pathologist and radiologist overlap. Orthopaedic oncology surgeons, musculoskeletal pathologists, bone radiologists, medical oncologists, reconstructive and reparative surgeons and medical radiation technologists from the Harvard Medical School, the Massachusetts General Hospital (Boston), the Beth Israel Deaconess Medical Center (Boston), the University of Hawaii, the Medical Oncology Department of the MD Anderson Cancer Center (Houston), the University of Puerto Rico and the La Paz University Hospital (Madrid) will be responsible for imparting the course in accordance with the precepts established since the course started by Dr. Henry J. Mankin.
December 4-5, 2014
The Japan-United States Workshop on Sarcoma Research and Therapy
Honolulu, Hawaii: In this meeting, many of the best sarcoma physicians, surgeons and researchers in Japan and the United States will speak. We welcome sarcoma specialists and patients and their families, and we have a patients adovocacy session with a poster presentation that will be organized by the Japanese patients group. For patients and families, the participation fee is $300 per 2 persons. Please e-mail for more information and view the event poster.
4th Cancer Targets and Therapeutics
Las Vegas,, California: The 4th Cancer Targets & Therapeutics Conference, taking place on February 25-26, 2013 in Las Vegas, NV will continue to be a premier event for translational researchers, preclinical scientists and managers, and those carrying out early phase clinical trials, working to identify and exploit advances in the field in order to deliver products with a meaningful clinical impact.
February 27-March 2, 2013
Conference on State of the Art Molecular Imaging
San Diego, California: This first joint meeting between the AACR and the Society of Nuclear Medicine and Molecular Imaging will bring together imaging scientists with biologists in basic, translational, and clinical research to explore how new findings in molecular imaging can improve cancer diagnostics, treatment, and patient outcomes.
March 5, 2013 at 2:30pm
What's Next in Next-Generation Sequencing?
Free Webinar: The webinar to be conducted in March will track the evolution of next-generation sequencing (NGS) and what the future holds in terms of the technology and its applications. Following brief presentations given by our panel of experts, there will be a live Q&A session where attendees can ask questions and discuss NGS-related challenges they are facing in their laboratories.
May 10-11, 2013
Course on the Diagnostic Histopathology of Soft Tissue Tumors
Treviso, Italy: The Department of Pathology of Treviso has organized a two-day course focused upon the diagnostic pathology and molecular genetics of soft tissue tumors. The course will be co-directed by Dr. Christopher Fletcher of Harvard Medical School. The course is directed to pathologists and will include lectures and slide seminars. Participants are kindly invited to submit one case for the slide seminar. The first 70 registrants will receive the slide box at the end of the course.
May 29-31, 2013
Meeting of the European MusuloSkeletal Oncology Society
September 27 - October 1, 2013
European Cancer Congress
Amsterdam, Netherlands: The European Cancer Congresses are the only multidisciplinary and multi-professional educational opportunity in oncology to take place in Europe – a fact that underpins the relevance, role and participation of each and every speciality in oncology. Thanks to this multidisciplinary collaboration, oncology professionals and patient advocates alike will be able to see and learn from the tangible benefits of cancer disciplines working together, with active patient involvement at the heart of discussions.
October 20 - November 2, 2013
18th Annual CTOS Meeting
New York, NY: CTOS is an international group comprised of physicians and scientists with a primary interest in the tumors of connective tissues. The goal of the society is to advance the care of patients with connective tissue tumors and to increase knowledge of all aspects of the biology of these tumors, including basic and clinical research.
January 6-7, 2014
Public Workshop: Complex Issues in Developing Drug and Biological Products for Rare Diseases
Silver Springs, Maryland: The purpose of this workshop is to discuss complex issues in clinical trials for developing drug and biological products (“drugs”) for rare diseases, including endpoint development and selection, use of surrogate endpoints and the accelerated approval pathway, clinical trial design, conduct and analysis, safety considerations, and dose selections; and to discuss ways to encourage and accelerate the development of new therapies for pediatric rare diseases. FDA is seeking input on these topics from academic, clinical, and treating communities; patients and advocacy groups; industry; and government agencies.
January 16-17, 2014
Access to Innovative Oncology Medicines in Europe
Bonn, Germany: This meeting will facilitate a collaborative discussion between regulatory bodies, HTA organizations, healthcare providers, patients and industry on the key reasons for inequalities in access to oncology treatments within and between countries and possible ways to overcome these access disparities.
January 27-28, 2014
Personalized Medicine World Conference
Mountain View, California
February 3-7, 2014
Course on Musculoskeletal Pathology
Bologna, Italy: This course is an update in musculoskeletal pathology with particular emphasis on bone and soft tissue tumors. The aim of the course is to improve knowledge and competence for these diseases. This year the course will be held jointly with staff from the Memorial Sloan-Kettering Cancer Center and the Hospital for Special Surgery in New York, NY. The course lasts 5 days and is held in English. The course is for Orthopaedic Surgeons, Pathologists, Radiologists, Oncologists, Radiotherapists and Basic Researchers who are interested in bone and soft tissue tumors.
February 8 - March 1, 2014
Targeting the PI3K/AKT/mTOR Pathway in Cancer
Barcelona, Spain: Building on the success of 2013, the second ESMO Symposium on Signalling Pathways in Cancer will focus on the PI3K/AKT/mTOR pathway. The programme has been designed provide oncology professionals with the latest scientific developments behind molecular pathways in cancer and a personalised approach to cancer treatment.
February 18-19, 2014
Sarcoma and GIST 2014
Milan, Italy: Sarcoma and GIST 2014 will offer participants a complete update of current medical therapy of these diseases from a multidisciplinary and clinical approach while also covering molecular and pathological issues.
February 25-28, 2014
Rare Disease Week
Washington, DC: You are invited to join Rare Disease Legislative Advocates and 200 rare disease advocates in Washington for Rare Disease Day (Week).
March 12-14, 2014
1st Immunotherapy of Cancer Conference (ITOC1)
Munich, Germany: ITOC-1 is the first European meeting intended to provide a platform for preclinical and clinical researchers in the field of immunotherapy. The concept is timely and necessary as agents have been licensed and arrived in clinical practice and many more similar drugs are expected to follow.
March 20, 2014
Free Webinar: Tools and Strategies Driving Cancer Immunotherapy
Online: The Scientist brings together a panel of experts who will delve into the hope and hype in an effort to educate the audience about the new findings in cancer immunotherapy. Attendees can interact with the experts during the live webinar by asking questions and sharing their experiences on this topic.
April 5-9, 2014
American Association for Cancer Research Annual Meeting 2014
San Diego, California: This year’s Annual Meeting theme, “Harnessing Breakthroughs - Targeting Cures,” reflects the great progress being made in cancer research as discoveries in the lab are translated into treatments in an increasingly targeted and precise manner. We will also continue to hold several sessions that will feature presentations of new data on cutting-edge clinical trials along with commentaries on the science behind the trials and the implications of these trials for improved patient care.
April 7, 2014
Current Developments in Soft Tissue Sarcoma Treatment
Vienna, Austria: The EORTC will host a joint session with ESTRO at ESTRO 33 focusing on current developments in soft tissue sarcoma treatment. It will take place from 14:30– 16:00 on Monday, 07 April 2014 in Vienna, Austria and will be co-chaired by Professors Jean-Yves Blay of the Centre Leon Berard in Lyon, France and past EORTC President and Philippe Maingon of the Centre Georges-François-Leclerc in Dijon, France, and Chair of the EORTC Radiation Oncology Group.
April 12-13, 2014
2014 New England Oncology Symposium
Providence, Rhode Island: Academic sessions will focus on the integration of surgery, chemotherapy and radiation therapy into the multidisciplinary management of several solid tumors. Emphasis will be on the utilization of energy devices for resection and ablation of solid tumors. Abdominal wall reconstruction for the cancer patient is another important topic we anticipate covering in the seminar.
May 1-4, 2014
2014 Oncology Nursing Congress
Anaheim, California: Congress is the oncology nursing conference that asks the big questions: Am I doing everything I can for patients with cancer? Am I teaching my staff or students to provide quality patient care? Over four days of fresh thinking, nurses will tackle the world of cancer care, from symptom management and treatment innovations to leadership, research, and administration.
May 30 - June 3, 2014
2014 ASCO Annual Meeting: Science & Society
Chicago, Illinois: The ASCO Annual Meeting attracts over 5,000 abstract submissions representing the latest in clinical and translational science in cancer prevention, diagnosis, and treatment. This cutting-edge research helps set the standard for cancer care in the United States and around the world.
June 23-24, 2014
WIN 2014 Symposium
Paris, France: The WIN 2014 Symposium is an exceptional global event entirely dedicated to breakthrough biomarker investigations and combination therapies for cancer. Major developments in precision cancer medicine will be developed in sessions featuring basic and clinical cancer research.
July 10-11, 2014
FDA Meeting on Laparoscopic Morcellator Devices & the Potential to Disseminate and Upstage Uterine Sarcomas
Silver Spring, MD: On July 10 and 11, 2014, the committee will discuss the safety of laparoscopic power morcellator devices as it pertains to their potential to disseminate and upstage a confined, but undetected (occult) uterine malignancy during laparoscopic hysterectomy or myomectomy. FDA is convening this committee to seek expert scientific and clinical opinion on the risks and benefits of these types of devices when used for these procedures, based on available scientific data. The committee will make recommendations regarding the appropriate use, premarket testing, labeling, and other risk mitigations (including the use of containment bags) for these devices. On July 11, 2014, during the afternoon session, the committee will also be asked to discuss the regulatory classification of laparoscopic power morcellator devices when used to cut and extract tissue during gynecologic laparoscopic procedures and to assist FDA in determining the appropriate level of regulatory control necessary for this device type, including discussion of class II (special controls) or reclassification to class III (subject to premarket approval application (PMA)).
July 17-19, 2014
47th Annual Musculoskeletal Tumor Meeting
Osaka, Japan: More than 1000 participants are expected, providing exceptional opportunity for pathologists, radiologists, pediatricians, medical oncologists, basic researchers, physical therapists and orthopaedic surgeons to exchange their experience and opinions while exploring new findings and evidences in all aspects of musculoskeletal tumors. The main theme of the upcoming meeting is "New Practical Approaches Against Sarcoma."
September 26-30, 2014
ESMO 2014 Congress
Madrid, Spain: The theme for ESMO 2014 is ‘Precision Medicine in Cancer Care.’ Whether you are a medical or surgical oncologist, radiotherapist, immunologist or pathologist, practicing precision medicine means we are all working towards a common goal—improved patient outcomes. This is the ultimate goal of ESMO 2014.
October 13-14, 2014
European Sarcoma and GIST Surgery Master Class
Villejuif, France: eSURGE is a European training programme exclusively dedicated to sarcoma and GIST surgery. This class is only open to surgeons and physicians.
October 15-18, 2014
2014 CTOS Annual Meeting
October 24-25, 2014
Palliative Care in Oncology Symposium
Boston, Massachusetts: The inaugural Palliative Care in Oncology Symposium is an exciting new educational opportunity for oncology professionals to learn how to integrate palliative care skills into cancer care across the trajectory of the illness.
February 6-8, 2012: Pediatric Cancer Translational Genomics
Scottsdale, Arizona: Join internationally recognized experts in the field of pediatric oncology for a collective conversation on how state-of-the-art genomics research may be applied to the translational oncology of pediatric solid tumors.
February 9-11, 2012: 18th Annual Network of Oncology Clinicians and Researchers (NOCR) Meeting
Las Vegas, Nevada: This annual update features clinical case and panel discussions, debates, and Meet the Expert sessions for exchanging the latest information on the diagnosis and management of solid tumors and hematologic malignancies. For 2012, we are expanding the agenda to include discussions on sarcoma and GIST, cutting-edge research in melanoma, and a special session on managing women’s issues in oncology.
February 29: Rare Disease Day Lobby Day
Join us for a Rare Disease Day Lobby Day in Washington DC to support ULTRA. The Unlocking Lifesaving Treatments for Rare diseases Act of 2012, or ULTRA, H.R. 3737, will improve access to the FDA's Accelerated Approval process for very rare diseases, provide a more predictable regulatory process, bring down development costs, and spur investment in the development of treatments. Additionally, ULTRA requires the FDA to use the best science available, ensuring treatments are safe and effective and reach patients sooner.
February 29 - March 2, 2012: British Sarcoma Group Conference
Oxford, United Kingdom
March 9-10: European Society for Medical Oncology Conference on Sarcoma and GIST
Milan, Italy: The 4th ESMO Conference on Sarcoma and GIST will provide a wide-ranging overview of current medical therapy of soft tissue sarcomas and GIST.
March 15-16: EORTC Group Annual Meeting
Brussels, Belgium: The EORTC Network comprises over 300 hospitals and cancer centers in over 30 countries which include some 2,500 collaborators from all disciplines involved in cancer treatment and research. The conference offers a unique opportunity to gather all the partners (including national research organizations, health authorities, patient advocacy groups, European Commission, cancer leagues, and the pharmaceutical industry) involved in the EORTC mission.
March 24 at 9:00am: "Meet the Sarcoma Experts" Forum
Boston, Massachusetts: This forum will be an educational experience for patients and their families at Massachusetts General Hospital. Topics covered include multidisciplinary treatment of sarcoma and advancements in sarcoma treatment. Please RSVP by March 19, 2012 to Donna Silva. Breakfast and refreshments will be served, and parking will be validated.
March 30 - April 1, 2012: The OMG! Cancer Summit
Las Vegas, California: An oncology conference and social networking event for the young adult cancer movement.
June 20, 2012: Online Sarcoma Support Group Meeting
Online: Memorial Sloan-Kettering Cancer Center will be hosting a live, online, confidential support group program for sarcoma patients on June 20th. This program is open to the public. Please feel free to make this information available to your community.
September 20-22, 2012
MusculoSkeletal Tumor Society (MSTS) Annual Meeting
in Tampa, Florida
September 29 - October 4
Molecular Biology and Innovative Therapies in Sarcomas of Childhood and Adolescence
in Polonia Castle in Pultusk, Poland: The conference will bring together biologists and clinicians to implement the interdisciplinary approach that is needed to advance research and therapy of rare childhood sarcomas.
November 14-17, 2012
Connective Tissue Oncology Society (CTOS) Annual Meeting
in Prague, Czech Republic
December 19, 2012
Virtual Sarcoma Support Group
Online: This group will provide an opportunity for patients with sarcoma to talk to each other in a live, online, confidential forum. This group will be facilitated by Linda Mathew, LCSW.
January 10-12, 2011: EuroBoNeT and Conticanet Annual Meeting
Paris, France: This meeting will be organised by EuroBoNeT and Conticanet, both European funded network of Excellences in their last year of European funding. EuroBoNeT is a network focussing on bone tumours (both benign and malignant) and bone formation. Their interests are divided into 4 main subjects: cartilage forming tumours (i.e. osteochondroma, enchondroma, chondrosarcoma), bone forming tumours (osteosarcoma, but also chordomas, angiosarcomas), giant cell tumour and bone formation, and Ewing sarcomas. The research focuses on pathology, biology and genetics of these tumours, in order to better understand how these tumours arise and how we might be able to treat them. Besides research, teaching of clinicians and pathologist is also part of their mission. Recently this resulted in publications on treatment guidelines on bone sarcomas and soft tissue sarcomas. Conticanet is a similar network, but focusing on connective tissue cancers. Together with EuroBoNeT they also were involved in the soft tissue sarcoma treatment guidelines and produced a similar one of GISTs.
February 9-11: The British Sarcoma Group Conference
Gateshead, United Kingdom: Details to be announced.
February 14-16: Practical clinical, radiological and pathological diagnosis of skeletal tumours
Leiden, Netherlands: This course aims at the practical histopathological diagnosis of tumours of bones and joints. It is meant for (trainee) pathologists, orthopaedic surgeons, radiologists, clinical oncologists and paediatricians. The course focuses on the use of clinical and radiodiagnostic data and the pathological differential diagnosis.
February 23-25: 18th International Molecular Medicine Tri-Conference
San Francisco, CA
March 7-9: 9th International Symposium on Targeted Anticancer Therapies
March 9-13: NCCN 16th Annual Conference
Hollywood, Florida: An NCCN Sarcoma Guidelines Update will take place at this conference on March 12 at 9:20am.
March 24: Optimal role of patient organisations in drug development
De Rode Hoed, Amsterdam, The Netherlands: Conference about how partnership with patient organisations can contribute to more efficient drug development
April 16: Meet the Sarcoma Experts - Fifth Annual Forum
Boston, Massachusetts: Fourteen sarcoma experts provide information about sarcoma and its treatment. RSVP by April 8th!
May 4-6: The 35th Meeting of the Scandinavian Sarcoma Group
Malmö Börshus, Malmö, Sweden
May 5: GIST Educational Meeting
Boston, Massachusetts: The GIST Cancer Research Fund is holding a special occasion of discovery and discussion highlighting new GIST research at Brigham and Women’s Hospital and the Dana-Farber Cancer Institute on Thursday, May 5th: 9:30-1:00PM (lunch provided). Please RSVP by Wednesday, April 27, to Christina Novak at 617. 424.4193. Space is limited. Speakers will be: James E. Butrynski, MD; George D. Demerti, MD; Janathan A. Fletcher, MD; Judy E. Garber, MD, MPH; Suzanne George, MD; Katherine A. Janeway, MD; Adrian Marino-Enriquez, MD; Amy S. Pilotte, NP; Kathleen M. Polson, NP; and Chandrajit P. Raut, MD.
September 14-18: Frontiers in Basic Cancer Research
San Francisco, California: This prestigious conference will be the second of its kind focused on the latest advances in basic cancer research. It is a broad-based meeting with the goals of presenting the best in basic cancer research and giving early-career investigators a unique opportunity to interact with luminaries in the field. The goal of the conference is to create a synergy between many subfields of basic cancer research that will encourage and strengthen collaborative efforts.
September 15-18: 16th International Symposium on Limb Salvage
September 23-27: The European Multidisciplinary Cancer Congress
Stockholm, Sweden: The biannual European Multidisciplinary Cancer Congresses have recently undergone a re-brand. Much more than a re-name and new tagline 'Integrating basic & translational science, surgery, radiotherapy, medical oncology & care,' the previous Congress has consequently been re-branded to visually encompass the 16th ECCO, the 36th ESMO and the 30th ESTRO Congresses as well as the essential contribution of all ECCO’s other Founding Members in partnership - ESSO, EACR, EONS and SIOPE.
October 15-16: Australian Sarcoma Group 2011 Annual Sarcoma Conference
October 27-29: Combined MSTS/CTOS Meeting
Chicago, IL: Sheraton Chicago Hotel and Towers
October 27 at 8am: 2011 SARC Meeting at CTOS
Chicago, IL: Sheraton Chicago Hotel and Towers
November 12-16: Molecular Targets and Cancer Therapeutics
San Francisco, California: This major conference brings together over 3,000 academics, scientists, and representatives from the pharmaceutical industry to discuss innovations in drug development, target selection and the impact of new discoveries in molecular biology.
November 17-19: 2nd SPAEN Annual Conference
Berlin, Germany: This will be the 2nd SPAEN Annual Conference for Organizations Representing Patients with Sarcomas, GIST or Desmoid Tumours. The conference aims to provide Sarcoma, GIST and Desmoid patient advocates with an opportunity to share experience and best practice, as well as to learn about advances and challenges in the treatment of rare cancers. The three day conference will focus on research, treatment and advocacy/capacity building. Leading European Sarcoma Experts will join us to present the latest news and answer your questions.
November 23-24: European Cancer Control Summit on the Role of Cancer Registries
Brussels, Belgium: Cancer registry funding organisations, epidemiological and clinical researchers, programme owners and managers will join policy-makers and patient advocates to discuss the value of high-quality information on cancer in Europe, particularly in terms of the development, analysis, optimal use and exchange of European cancer registry data at this high-level meeting.
December 15: CancerCare's Treatment Update on Soft Tissue Sarcoma
A free workshop for people living with soft tissue sarcoma, their families, friends and health care professionals. Pre-registration is required. Registered participants can join the call via a toll-free number and online streaming. Learn more by viewing the brochure.